News

Underuse of Aldosterone Antagonists Contributes to Heart Failure Deaths

Publish date: October 24, 2012

 

EXPERT ANALYSIS FROM THE ANNUAL MEETING OF THE HEART FAILURE SOCIETY OF AMERICA

Dr. Fonarow disclosed that he is a consultant to and/or receives honoraria or research funding from Novartis and Medtronic.

Pages

Recommended Reading

Psoriasis Plus Diabetes Equals Heightened Vascular Risk
MDedge Internal Medicine
Mean Serum Lipids Have Improved Since Late 1980s
MDedge Internal Medicine
Panel Supports Approval of Cholesterol Drug for Rare Disorder
MDedge Internal Medicine
Apps Proliferate Amid Concerns About Medical Use
MDedge Internal Medicine
Hepatic Concerns Influence Panel's Vote on ApoB Inhibitor
MDedge Internal Medicine
Higher MI Mortality in Hospitalized HIV Patients
MDedge Internal Medicine
FDA Expands Sapien Approval
MDedge Internal Medicine
Hip Fracture Risk Rises as Elderly Start Antihypertensives
MDedge Internal Medicine
Report Shows Snapshot of Invasive Cardiology in U.S.
MDedge Internal Medicine
Perceived Dyspnea Affects COPD Quality of Life Outcomes
MDedge Internal Medicine